Sarepta therapeutics prices $1.0 billion of convertible senior notes due 2027

With current cash and projected revenue, offering is expected to fund operations to profitability with current cash and projected revenue, offering is expected to fund operations to profitability

SRPT Ratings Summary

SRPT Quant Ranking